 |
인쇄하기
취소
|
Zuellig Pharma Korea’s profits up in 2011
Zuellig Pharma Korea (ZPK) said its operating profit rose 14.86 percent to 39.1 billion won on-year last year. The net profit soared by 57.01 percent to 4.67 billion won.
ZPK’s pain-in capital stands at 12 billion won, fully owned by foreign investors.
ZPK has benefited from being the first company in Korea to become a distributor of pharmaceutical products. Since its establishment, ZPK h...
ZPK’s pain-in capital stands at 12 billion won, fully owned by foreign investors.
ZPK has benefited from being the first company in Korea to become a distributor of pharmaceutical products. Since its establishment, ZPK h...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.